Researchers in Oxford are in the early stages of a planning a new clinical trial called Recurrent-GB for patients diagnosed with a Glioblastoma and would greatly appreciate any feedback on the trial design.
This survey will take approximately 5 minutes to complete and can be completed by a patient with the diagnosis, or a loved one.
Thanks for placing the post; I have completed it and offered to provide support in the development of the trial based upon my experience of the phase 1 SATIVEX clinical trial.🙂
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.